The European Union (EU) has awarded Aromics—a Spanish biotechnology company—€1 million (Euros) for its BERMES project that’s working on a novel mesothelioma drug. These funds will allow the company to finish its preclinical trials for this new drug, NAX035. The medical community needs to find effective targeted mesothelioma therapies because the disease has such a
The post Preclinical Trial for New Mesothelioma Drug Receives EU Funding appeared first on Mesothelioma Help Now.
from Mesothelioma Help Now https://ift.tt/2JloUKv
via IFTTT
Preclinical Trial for New Mesothelioma Drug Receives EU Funding
![Preclinical Trial for New Mesothelioma Drug Receives EU Funding]()
Reviewed by Unknown
on
March 18, 2019
Rating:
No comments: